Novel Drugs and Gene Therapy: What’s Next?

Basic research and emerging technologies have facilitated novel therapies with enormous potential to improve outcomes for patients with heart failure. This session will review these strategies, their limitations, and the populations most likely to benefit from these approaches.

Agenda

• Moderator - Forum Kamdar, MD, PhD, FHFSA
• Moderator - Victoria Parikh, MD
• Drugging the Sarcomere - Masataka Kawana, MD
• Genome Engineering - Victoria Parikh, MD
• Gene Therapy for DCM, Leveraging Success in Danon Disease - Eric Adler, MD
• Panel Discussion